Recursion Pharmaceuticals...

NASDAQ: RXRX · Real-Time Price · USD
5.49
0.92 (20.13%)
At close: Jun 06, 2025, 3:59 PM
5.85
6.65%
Pre-market: Jun 09, 2025, 05:45 AM EDT

Recursion Pharmaceuticals Statistics

Share Statistics

Recursion Pharmaceuticals has 399.66M shares outstanding. The number of shares has increased by 71.69% in one year.

399.66M
71.69%
2.96%
99.99%
310.78M
745,904
3.58%

Short Selling Information

The latest short interest is 104.22M, so 25.64% of the outstanding shares have been sold short.

104.22M
25.64%
27.66%
4.73

Valuation Ratios

The PE ratio is -4 and the forward PE ratio is -3.74. Recursion Pharmaceuticals's PEG ratio is -0.57.

-4
-3.74
31.5
11.3
1.79
-4.97
-0.57
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Recursion Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.1.

3.81
3.81
0.1
-0.25
-0.29
-304.71

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$73,548.75
$-579,576.25
800
0.04
n/a

Taxes

-1.13M
0.24%

Stock Price Statistics

The stock price has increased by -35.49% in the last 52 weeks. The beta is 0.83, so Recursion Pharmaceuticals's price volatility has been higher than the market average.

0.83
-35.49%
4.89
6.47
61.42
20,830,187

Income Statement

In the last 12 months, Recursion Pharmaceuticals had revenue of 58.84M and earned -463.66M in profits. Earnings per share was -1.69.

58.84M
13.6M
-479M
-463.66M
-426.72M
-463.22M
-1.69
Full Income Statement

Balance Sheet

The company has 594.35M in cash and 108.49M in debt, giving a net cash position of 485.86M.

594.35M
108.49M
485.86M
-1.43B
1.31B
442.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -359.17M and capital expenditures -13.7M, giving a free cash flow of -372.87M.

-359.17M
-13.7M
-372.87M
-1.36
Full Cash Flow Statement

Margins

Gross margin is 23.12%, with operating and profit margins of -814.09% and -788.02%.

23.12%
-814.09%
-789.93%
-788.02%
-725.24%
-814.09%
-633.71%

Dividends & Yields

RXRX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RXRX is $8, which is 45.7% higher than the current price. The consensus rating is "Hold".

$8
45.7%
Hold
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

0.15
1